EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Intellipharmaceutics International Inc. (V.IPC) had EBITDA Margin of -4023.32% for the most recently reported fiscal year, ending 2022-11-30.
| Income Statement Financials | |
-- |
|
-3.74M |
|
-- |
|
-- |
|
-- |
|
-3.69M |
|
-- |
|
-3.74M |
|
-3.74M |
|
-3.74M |
|
-3.74M |
|
-3.74M |
|
-3.74M |
|
-3.69M |
|
-3.42M |
|
33.09M |
|
33.09M |
|
-0.12 |
|
-0.12 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
1.85M |
|
-- |
|
-- |
|
-- |
|
15.55M |
|
-13.69M |
|
-13.69M |
|
-13.69M |
|
33.09M |
|
| Cash Flow Statement Financials | |
-1.80M |
|
0.65M |
|
0.26M |
|
1.00M |
|
0.11M |
|
-0.89M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-- |
|
-0.20 |
|
100.00% |
|
-4336.82% |
|
-4336.82% |
|
|
EBITDA Margin |
-4023.32% |
-4392.43% |
|
-4400.55% |
|
-1.15M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
27.35% |
|
27.35% |
|
-201.98% |
|
27.35% |
|
-0.41 |
|
-0.03 |
|
-0.05 |
|